NORTH YORK, ON / ACCESS Newswire / October 27, 2025 / ZTEST Electronics Inc. ("ZTEST" or the "Company") (CSE:ZTE)(OTCID:ZTSTF) announces fiscal 2025 revenues of $8,319,302, including $2,113,637 in Q4, representing the third consecutive quarter with very modest revenue growth. Revenues for the corresponding periods of 2024 were $9,756,044, inclusive of the record revenues of $2,791,359 in the final quarter. ...

Myriad Uranium Reports on Additional Chemical Assays From 34 Boreholes at Copper MountainThe New Results Enhance Uranium Grades, Extend Mineralised Intervals, and Identify Numerous Entirely New Mineralised Intervals.October 27, 2025 7:30 AM EDT | Source: Myriad Uranium Corp.Vancouver, British Columbia--(Newsfile Corp. - October 27, 2025) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) is pleased to report updated chemical assay results from October-November 2024 drilling at the Coppe ...

Roundhill Generative AI & Technology ETF (NYSEMKT: CHAT) takes an active management approach with concentrated positions in generative AI names. Launched in May 2023 with a 0.75% expense ratio, it offers options trading and suits investors wanting narrative-driven stock selection over index construction.iShares Future AI & Tech ETF (NYSEMKT: ARTY) delivers similar core AI exposure from BlackRock at a lower 0.47% expense ratio. The passive fund tilts toward established technology names with fundamental scree ...

In this articleGOOGLMETAAMZNMSFTNVDAMicrosoft CEO Satya Nadella, right, speaks as OpenAI CEO Sam Altman looks on during the OpenAI DevDay event in San Francisco on Nov. 6, 2023.Justin Sullivan | Getty ImagesOpenAI's head-spinning investments announced in recent months have led to increased scrutiny of the hyperscalers, which are all racing to develop infrastructure for the accelerating artificial intelligence boom.Investors are about to get a lot of new information to digest.Microsoft, Alphabet, Meta and Am ...

Core Viewpoint - Abaxx Technologies has integrated its futures markets data into TradingView, enhancing accessibility to its physically-backed LNG forward curves and Singapore Gold Kilobar Futures for a global audience of over 100 million users, thereby establishing new regional benchmarks for price discovery [1][2][3] Group 1: Integration and Market Access - The integration allows Abaxx's full suite of physically-deliverable futures contracts to be available for charting and analysis on TradingView, expanding distribution and enabling market participants to track Abaxx contracts alongside established benchmarks [2][3] - This move is seen as a significant step towards establishing trusted and transparent benchmarks in the market [3] Group 2: Product Offerings and Market Impact - Since its launch in June 2024, Abaxx Exchange has introduced ten new futures benchmark contracts across various sectors including energy, environmental, battery materials, and precious metals [3] - The visibility of these markets on TradingView is expected to integrate Abaxx products into the workflows of traders globally, supporting broader participation and reinforcing their role in global price discovery [3][9] Group 3: Company Overview - Abaxx Technologies aims to build smarter markets through better tools, benchmarks, and technology, addressing significant societal challenges such as the energy transition [8] - The company is the majority shareholder of Abaxx Singapore Pte. Ltd., which owns Abaxx Exchange and Abaxx Clearing, and operates Abaxx Spot, focusing on modernizing physical gold trading [8][10]

Core Viewpoint - BrainsWay Ltd. has made two additional strategic minority stake investments in U.S. mental health providers, bringing the total to four in 2025, aiming to enhance patient access to innovative mental health treatments and drive long-term shareholder value [1][2][5] Investment Details - BrainsWay will invest an initial $1.5 million in Heading Health, with the potential for an additional $2.5 million through three milestone-based investments [3] - The investment in Heading Health will provide BrainsWay with a minority position in the form of a preferred, annually compounding security [3] Strategic Intent - The investment strategy is designed to facilitate the growth of commercial partners while allowing BrainsWay to maintain its focus on scientific and technological advancements [4] - The partnership with Heading Health is seen as a unique opportunity to expand treatment options and improve patient lives on a large scale [5] Company Overview - BrainsWay is a leader in noninvasive neurostimulation treatments for mental health disorders, utilizing its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) technology [6] - The company has received FDA clearance for three indications, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction [6] Heading Health Overview - Heading Health specializes in interventional psychiatry, focusing on effective mental health protocols for conditions such as severe trauma, stress, anxiety, and depression [7] - The organization employs a team of board-certified psychiatrists and advanced psychiatric nurse practitioners to deliver cutting-edge treatment options [7]

Accessibility StatementSkip Navigation Allstate reports applications for new credit cards, loans and account setups peak in October during pre-Black Friday shopping, totaling more than $9M in potential losses Key takeaways: NORTHBROOK, Ill., Oct. 27, 2025 /PRNewswire/ -- Identity theft is ramping up earlier than expected. New data from Allstate Identity Protection shows a sharp rise in fraudulent account activity in October, surpassing November and December. The surge coincides with early holiday shopping ...

Accessibility StatementSkip Navigation Clinical remission rates were over 85% for both TREMFYA maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies At Week 96 (as observed)*:    TREMFYA 100 mg q8w TREMFYA 200 mg q4w | Clinical remission | | | | --- | --- | --- | | | 92.0% | 93.4% | | GRAVITI | 86.7% | 87.1% | | GALAXI 2, 3 (pooled) | | | | Endoscopic response | 65.0% | 65.1% | | GRAVITI | 73.6% | 70.7% | | GALAXI 2, 3 (pooled) | | | | Endoscopic remission | 41.5% | 46.0% | | GR ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Considering buying FIVE stock? Here’s what analysts think: Read This Next: Photo via ShutterstockLoading...Loading... ...

Core Insights - Wright National Flood Insurance Company is acquiring the assets of Poulton Associates to strengthen its position as the largest flood insurance provider in the US [1][5] - The acquisition is expected to be completed by November 2025, pending certain conditions [1] - Poulton Associates has been providing risk services since 1989 and operates the web platform CATcoverage.com [2] Company Overview - Wright Flood serves 4.7 million flood policyholders and offers a variety of flood insurance products, including federal, excess, and private options [4] - Poulton Associates offers coverage through its National Catastrophe Insurance Program and works with licensed insurance agents across all 50 US states [2] - The combined entity aims to deliver greater value to customers and increase the number of properties covered by flood insurance [4][6] Leadership Statements - Poulton Associates president Blake Poulton expressed excitement about the merger, highlighting the complementary nature of both companies' offerings [3] - Wright Flood CEO Patty Templeton-Jones emphasized the shared culture and focus on comprehensive flood insurance [4] - Arrowhead Programs president Tom Kussurelis noted that the merger will create the largest and most comprehensive flood insurance offerings in the market [5]